AUCTION NOTICE: Sterifre Medical Intellectual Property Portfolio

Sterifre Medical’s pioneering IP portfolio is now available in a court-supervised auction—a rare chance to acquire cutting-edge innovations in medical disinfection and sterilization. This sale is approved under the WA Receivership Court Order – Case no. 25-2-09005-1.

 Covers breakthrough devices, systems, and methods in:
*Free Radical Sterilization
*Microbial Burden Reduction
*Disinfection & Decontamination

 Patent Portfolio Highlights:
*23 total patents – 9 issues, 9 pending/allowed, 1 indeterminate
*Global patent protection – across the U.S., Europe, South America, and Asia

™️ Trademark Assets:
*18 registered trademarks (11 under Sterifre, 8 under AURA)
*16 global trademarks (10 under Sterifre, 6 under AURA)

 Flagship Innovation: AURA System
*First fully automated, point-of-care disinfection system
*Full-patented and wholly-owned
*Approved by Federal and State EPA agencies (approved in 33 states)
*EPA Registration No. 93728-2

 2025 Sales Timeline (Subject to change)
*Due diligence period: May 19-July 2
*Sales hearing: June 16
*Qualified bids due: July 7
*Auction date: July 8
NDA required for data room access

For full sale details and to access the data room, contact Erica Manning, CPA. Sale is subject to receivership court approval.